Bryostatin exerts anti-tumor effects by reversing T cell exhaustion

被引：0
|
作者：
Zhao, Manzhi [1 ]
Li, Ling [1 ]
Kiernan, Caoimhe H. [1 ]
Ruijten, Rik [1 ]
Alofs, Tessa [1 ]
Van Meurs, Marjan [1 ]
Haspels, Inge Brouwers [1 ]
Mueller, Yvonne M. [1 ]
Katsikis, Peter D. [1 ]
机构：
[1] Erasmus MC, Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Cancer immunology; immune regulation and therapy; immunotherapy;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OP-066
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [11] IDO inhibitor synergized with radiotherapy to delay tumor growth by reversing T cell exhaustion
    Liu, Meng
    Li, Ziyang
    Yao, Weirong
    Zeng, Xiaoping
    Wang, Lingyun
    Cheng, Jiao
    Ma, Bingyu
    Zhang, Ruiqian
    Min, Weiping
    Wang, Hongmei
    MOLECULAR MEDICINE REPORTS, 2020, 21 (01) : 445 - 453
  • [12] Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma
    Ken-ichi Kitazoe
    Masahiro Abe
    Masahiro Hiasa
    Asuka Oda
    Hiroe Amou
    Takeshi Harada
    Ayako Nakano
    Kyoko Takeuchi
    Toshihiro Hashimoto
    Shuji Ozaki
    Toshio Matsumoto
    International Journal of Hematology, 2009, 89 : 45 - 57
  • [13] Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma
    Kitazoe, Ken-ichi
    Abe, Masahiro
    Hiasa, Masahiro
    Oda, Asuka
    Amou, Hiroe
    Harada, Takeshi
    Nakano, Ayako
    Takeuchi, Kyoko
    Hashimoto, Toshihiro
    Ozaki, Shuji
    Matsumoto, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (01) : 45 - 57
  • [14] Reversing T-cell Dysfunction and Exhaustion in Cancer
    Zarour, Hassane M.
    CLINICAL CANCER RESEARCH, 2016, 22 (08) : 1856 - 1864
  • [15] THE EFFECTS OF CHEMOTHERAPY ON THE ANTI-TUMOR T CELL RECEPTOR REPERTOIRE IN PEDIATRIC NEUROBLASTOMA
    Nakano, Taizo
    Slansky, Jill
    Lovell, Mark
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S66 - S66
  • [16] Fucoidan exerts immunogenic anti-tumor effects through scavenger receptor type A
    Kwak, J. -Y.
    FEBS JOURNAL, 2013, 280 : 503 - 503
  • [17] Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML
    Yi-chen Lei
    Xin-jie Chen
    Yu-ting Dai
    Bing Dai
    Ji-yue Wang
    Miao-hui Li
    Ping Liu
    Han Liu
    Kan-kan Wang
    Lu Jiang
    Bing Chen
    Acta Pharmacologica Sinica, 2024, 45 : 633 - 645
  • [18] Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML
    Lei, Yi-chen
    Chen, Xin-jie
    Dai, Yu-ting
    Dai, Bing
    Wang, Ji-yue
    Li, Miao-hui
    Liu, Ping
    Liu, Han
    Wang, Kan-kan
    Jiang, Lu
    Chen, Bing
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (03) : 633 - 645
  • [19] The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
    Stefanie Tiede
    Nathalie Meyer-Schaller
    Ravi Kiran Reddy Kalathur
    Robert Ivanek
    Ernesta Fagiani
    Philip Schmassmann
    Patrick Stillhard
    Simon Häfliger
    Norbert Kraut
    Norbert Schweifer
    Irene C. Waizenegger
    Ruben Bill
    Gerhard Christofori
    Oncogenesis, 7
  • [20] The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer
    Tiede, Stefanie
    Meyer-Schaller, Nathalie
    Kalathur, Ravi Kiran Reddy
    Ivanek, Robert
    Fagiani, Ernesta
    Schmassmann, Philip
    Stillhard, Patrick
    Hafliger, Simon
    Kraut, Norbert
    Schweifer, Norbert
    Waizenegger, Irene C.
    Bill, Ruben
    Christofori, Gerhard
    ONCOGENESIS, 2018, 7
12345